Silencing HIPPI Suppresses Tumor Progression in Non-Small-Cell Lung Cancer by Inhibiting DNA Replication

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
   PubMed Web of Science ®Google Scholar
• Wanker EE. Hip1 and hippi participate in a novel cell death-signaling pathway. Dev Cell. 2002;2:126–128. doi:10.1016/S1534-5807(02)00121-1
   PubMed Web of Science ®Google Scholar
• Bhattacharyya NP, Banerjee M, Majumder P. Huntington’s disease: roles of huntingtin-interacting protein 1 (HIP-1) and its molecular partner HIPPI in the regulation of apoptosis and transcription. FEBS J. 2008;275:4271–4279. doi:10.1111/j.1742-4658.2008.06563.x
   PubMed Web of Science ®Google Scholar
• Majumder P, Chattopadhyay B, Mazumder A, Das P, Bhattacharyya NP. Induction of apoptosis in cells expressing exogenous hippi, a molecular partner of huntingtin-interacting protein Hip1. Neurobiol Dis. 2006;22:242–256. doi:10.1016/j.nbd.2005.11.003
   PubMed Web of Science ®Google Scholar
• Majumder P, Choudhury A, Banerjee M, Lahiri A, Bhattacharyya NP. Interactions of HIPPI, a molecular partner of huntingtin interacting protein HIP1, with the specific motif present at the putative promoter sequence of the caspase-1, caspase-8 and caspase-10 genes. FEBS J. 2007;274:3886–3899. doi:10.1111/j.1742-4658.2007.05922.x
   PubMed Web of Science ®Google Scholar
• Majumder P, Chattopadhyay B, Sukanya S, et al. Interaction of HIPPI with putative promoter sequence of caspase-1 in vitro and in vivo. Biochem Biophys Res Commun. 2007;353:80–85. doi:10.1016/j.bbrc.2006.11.138
   PubMed Web of Science ®Google Scholar
• Niu Q, Ybe JA. Crystal structure at 2.8 A of Huntingtin-interacting protein 1 (HIP1) coiled-coil domain reveals a charged surface suitable for HIP1 protein interactor (HIPPI). J Mol Biol. 2008;375:1197–1205. doi:10.1016/j.jmb.2007.11.036
   PubMed Web of Science ®Google Scholar
• Stanton SE, Blanck JK, Locker J, Schreiber-Agus N. Rybp interacts with hippi and enhances hippi-mediated apoptosis. Apoptosis. 2007;12:2197–2206. doi:10.1007/s10495-007-0131-3
   PubMed Web of Science ®Google Scholar
• Backendorf C, Visser AE, de Boer AG, et al. Apoptin: therapeutic potential of an early sensor of carcinogenic transformation. Annu Rev Pharmacol Toxicol. 2008;48:143–169. doi:10.1146/annurev.pharmtox.48.121806.154910
   PubMed Web of Science ®Google Scholar
• Cheng CM, Huang SP, Chang YF, Chung WY, Yuo CY. The viral death protein apoptin interacts with hippi, the protein interactor of huntingtin-interacting protein 1. Biochem Biophys Res Commun. 2003;305:359–364. doi:10.1016/S0006-291X(03)00764-2
   PubMed Web of Science ®Google Scholar
• Sakamoto K, Yoshida S, Ikegami K, et al. Homer1c interacts with hippi and protects striatal neurons from apoptosis. Biochem Biophys Res Commun. 2007;352:1–5. doi:10.1016/j.bbrc.2006.10.167
   PubMed Web of Science ®Google Scholar
• Datta M, Bhattacharyya NP. Regulation of RE1 protein silencing transcription factor (REST) expression by HIP1 protein interactor (HIPPI). J Biol Chem. 2011;286(39):33759–33769. doi:10.1074/jbc.M111.265173
   PubMed Web of Science ®Google Scholar
• Gdynia G, Lehmann-Koch J, Sieber S, et al. BLOC1S2 interacts with the HIPPI protein and sensitizes NCH89 glioblastoma cells to apoptosis. Apoptosis. 2008;13:437–447. doi:10.1007/s10495-007-0176-3
   PubMed Web of Science ®Google Scholar
• Datta M, Choudhury A, Lahiri A, Bhattacharyya NP. Genome wide gene expression regulation by HIP1 protein interactor, HIPPI: prediction and validation. BMC Genomics. 2011;12:463. doi:10.1186/1471-2164-12-463
   PubMed Web of Science ®Google Scholar
• Regzedmaa O, Li Y, Li Y, et al. Prevalence of DLL3, CTLA-4 and MSTN expression in patients with small cell lung cancer. Onco Targets Ther. 2019;12:10043–10055. doi:10.2147/OTT.S216362
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47. doi:10.1093/nar/gkv007
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhou B, Pache L, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10:1523. doi:10.1038/s41467-019-09234-6
   PubMed Web of Science ®Google Scholar
• Jamal-Hanjani M, Wilson GA, McGranahan N, et al. Tracking the evolution of non-small-cell lung cancer. N Engl J Med. 2017;376:2109–2121. doi:10.1056/NEJMoa1616288
   PubMed Web of Science ®Google Scholar
• Herbst R, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553:446–454. doi:10.1038/nature25183
   PubMed Web of Science ®Google Scholar
• Huang W, Yan Y, Liu Y, et al. Exosomes with low miR-34c-3p expression promote invasion and migration of non-small cell lung cancer by upregulating integrin α2β1. Signal Transduct Target Ther. 2020;5:39. doi:10.1038/s41392-020-0133-y
   PubMed Web of Science ®Google Scholar
• Rotow J, Bivona TG. Understanding and targeting resistance mechanisms in NSCLC. Nat Rev Cancer. 2017;17:637–658.
   PubMed Web of Science ®Google Scholar
• Li Z, Xu X. Post-translational modifications of the mini-chromosome maintenance proteins in DNA replication. Genes. 2019;10:331.
   PubMed Web of Science ®Google Scholar
• Jang N, Baek J, Ko Y, Song P, Gu M. High MCM6 expression as a potential prognostic marker in clear-cell renal cell carcinoma. In Vivo. 2021;35:299–306. doi:10.21873/invivo.12259
   PubMed Web of Science ®Google Scholar
• Yu S, Wang G, Shi Y, Xu H, Zheng Y, Chen Y. MCMs in cancer: prognostic potential and mechanisms. Anal Cell Pathol. 2020;2020:3750294. doi:10.1155/2020/3750294
   Web of Science ®Google Scholar
• Wu W, Wang X, Shan C, Li Y, Li F. Minichromosome maintenance protein 2 correlates with the malignant status and regulates proliferation and cell cycle in lung squamous cell carcinoma. Onco Targets Ther. 2018;11:5025–5034. doi:10.2147/OTT.S169002
   PubMed Web of Science ®Google Scholar
• Dehan E, Ben-Dor A, Liao W, et al. Chromosomal aberrations and gene expression profiles in non-small cell lung cancer. Lung Cancer. 2007;56:175–184. doi:10.1016/j.lungcan.2006.12.010
   PubMed Web of Science ®Google Scholar
• Cao T, Yi S, Wang L, et al. Identification of the DNA replication regulator MCM complex expression and prognostic significance in hepatic carcinoma. Biomed Res Int. 2020;2020:3574261. doi:10.1155/2020/3574261
   PubMed Web of Science ®Google Scholar
• Deng Y, Ma H, Hao J, Xie Q, Zhao R. MCM2 and are potential biomarkers for the diagnosis and prognosis of pancreatic cancer. Biomed Res Int. 2020;2020:8604340. doi:10.1155/2020/8604340
   PubMed Web of Science ®Google Scholar
• Liu M, Li J, Tian D, Huang B, Rosqvist S, Su M. MCM2 expression levels predict diagnosis and prognosis in gastric cardiac cancer. Histol Histopathol. 2013;28(4):481–492. doi:10.14670/HH-28.481
   PubMed Web of Science ®Google Scholar
• Issac M, Yousef E, Tahir M, Gaboury L. MCM2, MCM4, and MCM6 in breast cancer: clinical utility in diagnosis and prognosis. Neoplasia. 2019;21(10):1015–1035. doi:10.1016/j.neo.2019.07.011
   PubMed Web of Science ®Google Scholar
• Huang B, Lin M, Lu L, et al. Identification of mini-chromosome maintenance 8 as a potential prognostic marker and its effects on proliferation and apoptosis in gastric cancer. J Cell Mol Med. 2020;24(24):14415–14425. doi:10.1111/jcmm.16062
   PubMed Web of Science ®Google Scholar